Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: the PARACOR-19 randomized clinical trial

Back

HFA Premium Access

Sacubitril/valsartan and cardiovascular biomarkers among patients with recent COVID-19 infection: the PARACOR-19 randomized clinical trial

Session: ePosters in chronic heart failure - biomarkers 1

Topic: Biomarkers

Speaker: Doctor S. Greene (Durham, US)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Stephen Greene

Duke Clinical Research Institute, Durham (United States of America)

10 presentations

2 followers

5 more presentations in this session

Rational use of natriuretic peptide testing in primary care - an observational study from a Danish regional hospital

Speaker: Doctor L. Lylloff (Herning, DK) Associate Professor N. Hornung (Herning, DK)

Correlation of NT-proBNP and residual ischemic risk in patients with heart failure and myocardial revascularization.

Speaker: Mrs J. Cazacu (Chisinau, MD)

CA125 assessment using ABEI-based assay in heart failure: implications for disease severity and cardiac biomarkers

Speaker: Professor D. Gruson (Brussels, BE)

The relationship of natriuretic peptides and body mass index in chronic heart failure, a systematic review

Speaker: Professor C. Ross (Edinburgh, GB)

QRS complex duration and type conduction disturbances as a simple predictor of left ventricle remodelation in patients with recent onset of dilated cardiomyopathy?

Speaker: Professor R. Pudil (Prague, CZ)

Access the full session

ePosters in chronic heart failure - biomarkers 1

Speakers: Doctor S. Greene, Doctor L. Lylloff, Associate Professor N. Hornung, Mrs J. Cazacu, Professor D. Gruson...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources